David McWilliams
Président chez GREENWICH LIFESCIENCES, INC.
Fortune : 11 M $ au 30/06/2024
Profil
David B.
McWilliams is currently the Chairman at BioHouston, Inc., Chairman at Greenwich LifeSciences, Inc., Director at Texas Healthcare & Bioscience Institute, Director at Norwell Mfg.
Co., Inc., and Member at The Phi Beta Kappa Society.
Previously, he served as the President, Chief Executive Officer & Director at Encysive Pharmaceuticals, Inc. from 1992 to 2002.
He was also the Chief Executive Officer & Director at Signase, Inc., President & Chief Executive Officer at Bacterial Barcodes, Inc., President & Chief Executive Officer at Opexa Therapeutics, Inc., President & Chief Executive Officer at Kallestad Diagnostics, Inc., and Director at Repros Therapeutics, Inc. Additionally, he served as a Director at Novelos Therapeutics, Inc., Director at Technology & Entrepreneurship Center of Houston, Director at ApoCell, Inc., General Manager at Abbott Laboratories, Management Consultant at McKinsey & Co., Inc., and President-Harleco Diagnostics Division at EM Industries LLC.
Mr. McWilliams holds an MBA degree from The University of Chicago and an undergraduate degree from Washington & Jefferson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2024 | 620 327 ( 4,82% ) | 11 M $ | 30/06/2024 |
Postes actifs de David McWilliams
| Sociétés | Poste | Début |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Président | 01/02/2009 |
BioHouston, Inc.
 BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Président | - |
Norwell Mfg. Co., Inc.
 Norwell Mfg. Co., Inc. Electrical ProductsProducer Manufacturing Norwell Mfg. Co., Inc. manufactures and sells interior and exterior lighting products. The company is headquartered in East Taunton, MA. | Directeur/Membre du Conseil | - |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Corporate Officer/Principal | - |
Texas Healthcare & Bioscience Institute
 Texas Healthcare & Bioscience Institute Miscellaneous Commercial ServicesCommercial Services Texas Healthcare & Bioscience Institute is a membership association that serves as a public policy voice for the healthcare and bioscience industry. The non-profit company is based in Austin, TX. | Directeur/Membre du Conseil | - |
Anciens postes connus de David McWilliams
| Sociétés | Poste | Fin |
|---|---|---|
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | Directeur/Membre du Conseil | 08/04/2011 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Directeur Général | 01/06/2008 |
Bacterial Barcodes, Inc.
 Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Directeur Général | 01/12/2003 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Directeur Général | 25/03/2002 |
| ░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de David McWilliams
| The University of Chicago | Masters Business Admin |
| Washington & Jefferson College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| GREENWICH LIFESCIENCES, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
| Signase, Inc. | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Bacterial Barcodes, Inc.
Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Health Technology |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Commercial Services |
Technology & Entrepreneurship Center of Houston
 Technology & Entrepreneurship Center of Houston Investment ManagersFinance Technology & Entrepreneurship Center of Houston operates as a non-profit organization created to accelerate the growth of Houston’s innovation ecosystem. It aligns ecosystem support around strategic initiatives that are connecting, attracting, and promoting startups, investors, corporations, government, and universities. The company was founded in October 2017 and is headquartered in Houston, TX. | Finance |
Texas Healthcare & Bioscience Institute
Texas Healthcare & Bioscience Institute Miscellaneous Commercial ServicesCommercial Services Texas Healthcare & Bioscience Institute is a membership association that serves as a public policy voice for the healthcare and bioscience industry. The non-profit company is based in Austin, TX. | Commercial Services |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Commercial Services |
ApoCell, Inc.
 ApoCell, Inc. Medical/Nursing ServicesHealth Services ApoCell, Inc. engages in molecular biomarker detection. It offers platform technologies, assay development, circulating tumor cells, genomics, flow cytometry, FISH and immunohistochemistry, immunofluorescence image analysis and cytokine Profiling services. The company was founded by Darren W. Davis in 2004 and is headquartered in Houston, TX. | Health Services |
Norwell Mfg. Co., Inc.
Norwell Mfg. Co., Inc. Electrical ProductsProducer Manufacturing Norwell Mfg. Co., Inc. manufactures and sells interior and exterior lighting products. The company is headquartered in East Taunton, MA. | Producer Manufacturing |
| Kallestad Diagnostics, Inc. | |
| EM Industries LLC |
